Follow
marina noris
marina noris
Verified email at marionegri.it
Title
Cited by
Cited by
Year
Atypical hemolytic–uremic syndrome
M Noris, G Remuzzi
New England Journal of Medicine 361 (17), 1676-1687, 2009
16132009
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype
M Noris, J Caprioli, E Bresin, C Mossali, G Pianetti, S Gamba, E Daina, ...
Clinical Journal of the American Society of Nephrology 5 (10), 1844-1859, 2010
12232010
Overview of complement activation and regulation
M Noris, G Remuzzi
Seminars in nephrology 33 (6), 479-492, 2013
9072013
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
J Caprioli, M Noris, S Brioschi, G Pianetti, F Castelletti, P Bettinaglio, ...
Blood 108 (4), 1267-1279, 2006
8812006
Hemolytic uremic syndrome
M Noris, G Remuzzi
Journal of the American Society of Nephrology 16 (4), 1035-1050, 2005
7442005
Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions
M Noris, M Morigi, R Donadelli, S Aiello, M Foppolo, M Todeschini, ...
Circulation research 76 (4), 536-543, 1995
7091995
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura
P Ruggenenti, M Noris, G Remuzzi
Kidney international 60 (3), 831-846, 2001
6952001
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference
THJ Goodship, HT Cook, F Fakhouri, FC Fervenza, V Frémeaux-Bacchi, ...
Kidney international 91 (3), 539-551, 2017
6452017
Thrombomodulin mutations in atypical hemolytic–uremic syndrome
M Delvaeye, M Noris, A De Vriese, CT Esmon, NL Esmon, G Ferrell, ...
New England Journal of Medicine 361 (4), 345-357, 2009
6392009
Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells
F Casiraghi, N Azzollini, P Cassis, B Imberti, M Morigi, D Cugini, ...
The Journal of Immunology 181 (6), 3933-3946, 2008
5522008
Mechanisms of disease: pre-eclampsia
M Noris, N Perico, G Remuzzi
Nature clinical practice Nephrology 1 (2), 98-114, 2005
4842005
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
M Noris, F Mescia, G Remuzzi
Nature Reviews Nephrology 8 (11), 622-633, 2012
4812012
Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype
E Bresin, E Rurali, J Caprioli, P Sanchez-Corral, V Fremeaux-Bacchi, ...
Journal of the American Society of Nephrology 24 (3), 475-486, 2013
4142013
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome
T Manuelian, J Hellwage, S Meri, J Caprioli, M Noris, S Heinen, M Jozsi, ...
The Journal of clinical investigation 111 (8), 1181-1190, 2003
4062003
Familial haemolytic uraemic syndrome and an MCP mutation
M Noris, S Brioschi, J Caprioli, M Todeschini, E Bresin, F Porrati, ...
The Lancet 362 (9395), 1542-1547, 2003
3702003
Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility
N Perico, F Casiraghi, M Introna, E Gotti, M Todeschini, RA Cavinato, ...
Clinical Journal of the American Society of Nephrology 6 (2), 412-422, 2011
3672011
The case of complement activation in COVID-19 multiorgan impact
M Noris, A Benigni, G Remuzzi
Kidney international 98 (2), 314-322, 2020
3632020
Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease
J Caprioli, F Castelletti, S Bucchioni, P Bettinaglio, E Bresin, G Pianetti, ...
Human molecular genetics 12 (24), 3385-3395, 2003
3462003
The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20
J Caprioli, P Bettinaglio, PF Zipfel, B Amadei, E Daina, S Gamba, ...
Journal of the American Society of Nephrology 12 (2), 297-307, 2001
3312001
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy
M Noris, M Galbusera, S Gastoldi, P Macor, F Banterla, E Bresin, ...
Blood, The Journal of the American Society of Hematology 124 (11), 1715-1726, 2014
3272014
The system can't perform the operation now. Try again later.
Articles 1–20